Large-scale genomic studies, such as The Cancer Genome Atlas (TCGA) project, have provided critical insights into the genomic landscape and heterogeneity of breast cancer, revealing a higher frequency of ESR1 mutations in MBC. The gene discussed is ESR1; the disease is breast carcinoma.